Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
aims to build novel databases and software suites to lower the barrier to computational analysis of clinical data modalities and to provide accurate in-depth simulations of disease evolution with
-
translational cancer research. Omics based strategies, such as (epi-)genomics and transcriptomics, are opening unprecedented potential for developing novel precision oncology tools for improved diagnosis
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large
-
/microglia-based 3D models recapitulating neural-microglia interactions, using biomaterials and (micro)tissue engineering approaches. The innovative aspect of the project will be in developing new analysis
-
set a course for the future – a future that you can help to shape. The EMAT research group at the Faculty of Science (University of Antwerp) is seeking to fill a PhD position on the development
-
such as the ELIXIR consortium, a European research infrastructure connecting life science resources. The Role A key mission of the VIB Data Core is to develop and maintain infrastructure for the secure
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large